fect, leads to cell swelling and eventual cell lysis, i.e., escape of hemoglobin. This mechanism of hemolysis was described in 1936 by Davson (8) and was termed colloid-osmotic hemolysis by Wilbrandt in 1941 (9) . Recently, Dick has summarized the topic clearly (10) . An analogous system has been demonstrated by Goldberg, Green, Barrow, and Fleischer (11) (12) (13) in their studies of the lysis of Krebs ascites tumor cells by rabbit antibody and C'. The cells exposed to antibody and C' rapidly became permeable to cations and other small molecules. Cell swelling and escape of larger molecules such as RNA were prevented by increasing the osmotic pressure of the external medium with added albumin. Since sucrose did not prevent cell swelling or loss of the large molecules of the cell, these authors concluded that antibody and C' had created functional "holes" in the cell membrane of a size between that of sucrose and albumin and that osmotic swelling was necessary to permit the egress of large molecules from the damaged cells. Based on these observations and the finding of a similar mechanism in antibody-C' lysis of mouse erythrocytes, Green and Goldberg (14) have suggested that colloid osmotic lysis is a general mechanism by which animal cells injured by antibodies and C' are lysed.
Our investigation was designed to study antibody-C' hemolysis of human red cells in vitro utilizing methods similar to those employed by Green and associates (13) to determine if antibody-C' hemolysis proceeded by a colloid-osmotic mechanism in this situation and to quantitate the size of induced membrane defects. If the action of antibody and C' produces membrane de- fects too small to permit the direct egress of hemoglobin, cell swelling and hemolysis should be prevented by the addition to the medium of nonpenetrating and, therefore, osmotically active molecules in appropriate concentrations to balance the greater intracellular osmotic pressure. Since only molecules larger than the membrane defect remain outside the cell and thus prevent cell swelling and hemolysis, an estimate of the size of the membrane defect can be obtained by testing molecules of various known sizes in the medium. In the present study, we have investigated the effects of sucrose, bovine serum albumin, human hemoglobin, and dextran fractions of various molecular sizes on in vitro hemolysis of human red cells by three different antisera and C'.
Methods and Materials
Red blood cells. Blood was obtained from hematologically normal adult male and female donors of groups A, B, AB, and 0; both Rh-positive and -negative donors were included. A fraction of blood was mixed with approximately 1 U of heparin per ml of blood, and the sample was centrifuged at 1,700 X g for 10 minutes. The plasma and buffy coat were removed by aspiration and the red cells washed three times with 5 vol of 1% sodium chloride.
Complement. A second sample of the same blood from which red cells were obtained was allowed to clot for 1 hour at room temperature. The serum was removed and utilized as a source of C'.
Rabbit antihuman red cell seruom. Blood was collected in standard acidified citrate dextrose from a type 0, Rh.+, NN human donor. The red cells were separated and washed four times with 3 vol of 0.9%o sodium chloride. One ml of packed red cells was injected intravenously into each of four 2-to 3-kg adult rabbits. Similar injections were repeated twice at 10-day intervals. Eight and 11 days after the third immunization, the rabbits were bled from ear veins, and serum was collected. The sera from the four rabbits were pooled and heated for 30 minutes at 560 C, Seitz-filtered, and stored in the frozen state at -20°C. To ascertain the antibody titer of this serum, fresh, washed human red cells of groups A, B, AB, and 0 were prepared as 3% suspensions in fresh autologous serum. Portions of these red cell suspensions were incubated for 1 hour at 370 C with saline dilutions of the pooled rabbit serum. Hemolysis and direct agglutination were then observed, and, in tubes beyond the agglutination end point, antiglobulin tests were performed on (19) were carried out on the whole sample and the supernatant medium after incubation. Hematocrits were determined by the microhematocrit method. The percentage of hemoglobin loss from the erythrocytes was then calculated by the following formula: OD supernatant medium X (100 -hematocrit)/OD whole sample X dilution factor. Even in experiments in which no protective macromolecules were added to the medium, the percentage of loss of hemoglobin from the cells in each sample was somewhat less than the percentage of loss of potassium. This differ-ence was accounted for by the retention of some hemoglobin by the lysed red cells. Hemoglobin retention by red cell ghosts is well recognized and has been described by Ponder (20) and Passow and Potassium determinations. Potassium was determined in samples and standard solutions by flame photometry5 utilizing an internal lithium standard. The percentage of red cell potassium lost to the medium during incubation was calculated from the potassium content of the red cells before incubation, that of the supernatant fluid before and after incubation, and that of the sample volume and the hematocrit after incubation.
In some experiments, the osmotic fragility of the unhemolyzed red cells was determined after incubation by the method of Parpart and colleagues (22) . Red cells and red cell ghosts were quantitated by counting with a Coulter model A electronic particle counter.6 Ultrafiltration was performed according to the method of Toribara (23) .
Osmotic pressure measurements. The concentration, and hence osmotic pressure, of hemoglobin in the cell is much greater than the concentration of protein in serum.
In these experiments the addition of macromolecules to the medium was designed to balance this greater osmotic pressure and thus to prevent cell swelling. The concentrations of albumin and other macromolecules used were selected both on the basis of published data on the osmolarity of hemoglobin and the osmolarity of serum albumin, as well as on the results of some direct measurements of osmolarity. Osmotic pressure measurements on concentrated albumin solutions have been reported by 5 Baird-Atomic flame photometer, Baird Atomic, Inc., Cambridge, Mass. 6 Coulter Electronics, Hialeah, Fla.
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Scatchard, Batchelder, and Brown (24) and on concentrated hemoglobin solutions by Adair (25) . Comparison of these data indicates that the concentrations of albumin used in these experiments were adequate to balance the osmotic pressure exerted by the intracellular hemoglobin. Total osmolarity measurements were performed with a vapor pressure osmometer 7 standardized with sodium chloride solutions. When the osmotic pressure of normal human serum was compared with that of serum to which 2.6 mM albumin had been added, an increase of 38 mOsm per L was observed. However, ultrafiltration of a solution of the bovine serum albumin in deionized water and subsequent osmotic pressure measurements on the ultrafiltrate demonstrated that such solutions contained 20 mOsm per L of ultrafiltrable nonprotein material of which approximately 10% was found to be sodium chloride. Since the ultrafiltrable material could be expected to cross altered, cation-permeable red cell membranes, however, the effective increment in osmotic pressure due to added macromolecules in a 2.6 mM solution of this albumin in serum was 18 mOsm per L. This figure is in good agreement with that of Scatchard and co-workers (24) and is comparable to the osmotic pressure of intracellular hemoglobin as discussed by Adair (25) . Since the ultrafiltrable material would not be expected to offer protection, it was not removed. Although adequate centrifugation of cells from 2.6 mM added albumin is not possible, measurement of the volume of normal cells in 2.0 mM added albumin reveals no significant change in cell volume.
The osmotic coefficient of dextran, like that of albumin and hemoglobin, has been shown by Rowe (26) and Gr6nwall and Ingelman (27) (Figure 1 ). Potassium loss from the red cells was unaltered, but hemoglobin loss was greatly inhibited. With 3.9 mM albumin added to the medium,8 72% of the red cell potassium was lost but only 5% of the hemoglobin. Antibody and C' had altered the cation permeability of the cell membrane to allow potassium escape. Hemolysis had been prevented because of the osmotic effect of the added albumin, which balanced the osmotic pressure of the macromolecules in the cell and prevented cell swelling.
To substantiate this interpretation further, we determined the osmotic fragility of cells thus "protected" by albumin against hemolysis. During 2 hours of incubation only 19% of the hemoglobin escaped to the medium, whereas 91 % of the red cell potassium was lost. The osmotic fragility of these cells (Figure 2) showed that 8 The albumin concentrations refer to the amounts added to the medium and do not include the concentration of albumin, or other macromolecules, already present in the serum. Control samples incubated without antibody or with C' inactivated showed essentially normal osmotic fragility. Thus, the cells incubated with antibody in the presence of albumin clearly had become permeable to sodium as well as to potassium.
When Dextran 40 (weight average molecular weight, 35,700) was added to the medium, the results were similar to those obtained with albumin (Figure 3 ). L'bss of potassium was unaffected, but loss of hemoglobin was almost totally inhibited by the higher concentrations of dextran. As in the experiments with albumin, dilution of the medium of the dextran-protected red cells with 1% saline for osmotic fragility determinations resulted in marked hemolysis; the extent of the hemolysis again agreed closely with the amount of potassium lost before dilution.
To define the lower limit of size of molecules that could protect against loss of hemoglobin, Dextran 10 (weight average molecular weight, 9,400), Dextran 20 (weight average molecular weight, 22,700), and sucrose (molecular weight, 342) were added to the medium in similar experiments. Figure 4 illustrates the results obtained utilizing Dextran Figure 5 . Concentrations of Dextran 20 higher than 4.5 mM appeared to decrease C' activity as evidenced by a decrease in loss of potassium, and therefore it was not possible to study concentrations of Dextran Studies utilizing human anti-A. The previous experiments were repeated to compare the effects of human anti-A and C' on group A1 human red cells with those obtained with rabbit antihuman red cell serum. Figure 6 shows the results of such a study. Albumin failed to provide the complete protection against hemolysis observed in the experiments with rabbit antihuman red cell antibody.
Since the bovine serum albumin molecule is larger than human hemoglobin, we concluded that the action of human anti-A and C' produced red cell membrane defects large enough to permit the direct escape of hemoglobin without the necessity of prior cell swelling. To support this conclusion, an experiment was designed in which human hemoglobin was added to the extracellular medium. It was not technically possible to achieve as concentrated solutions of hemoglobin in the medium as had been utilized with albumin. Nevertheless, Figure 7 illustrates that at molar concentrations of extracellular hemoglobin analogous to concentrations of albumin (Figure 1 ), which were significantly protective against antihuman red cell serum, hemoglobin failed to inhibit hemolysis. We concluded that human anti-A antiserum, in contrast to rabbit antihuman red cell antiserum, produced membrane defects of sufficient size to permit hemoglobin escape from the cell directly without prior cell swelling. The results agree with and extend the observation of Jacob and Jandl (28) the medium did not prevent hemolysis by human anti-A and C'.
Studies utilizing fractionated antisera. Goodman (29) and Johnson, Woernley, and Pressman (30) have found that the rabbit produces 7 S Y2 hemolysin when immunized repeatedly with human red cells. Hemolytic activity in human anti-A sera has been found in both 7 S and 19 S fractions by McDuffie, Kabat, Allen, and Williams (31). The 7 S fraction of the rabbit antihuman red cell serum was incubated with human group A1 red cells with and without added albumin; the results of this experiment are shown in Table I . Loss of hemoglobin produced by the 7 S fraction of the rabbit antihuman red cell antibody was markedly inhibited by albumin, whereas loss of potassium was unaffected. These results are identical to those observed with the unfractionated antiserum. The total loss of hemoglobin and potassium produced by the amount of the 7 S fraction of human anti-A employed in these experiments did not exceed 28%; there was still no significant inhibition of loss of hemoglobin relative to loss of potassium in albumin protected tests. These results are comparable to those obtained with the unfractionated anti-A serum. In summary, the 7 S antibody fractions containing the hemolytic activity of these antisera behaved like the respective whole native sera in terms of the size of the defects induced in the red cell membrane. The size of the membrane (Table  II) . Thus, rabbit antihuman A produced membrane defects of greater size than the hemoglobin molecule. Its action in this respect was similar to human anti-A and different from rabbit antihuman red cell serum. The difference in results between the two antisera of rabbit origin, but of different specificity, indicates that the size of the membrane defect created by antibody and C' does not appear to be a characteristic of the animal species in which the antibody is produced. Rather, the characteristic size of the membrane defect appears to be related to the antigen against which the antibody is directed, i.e., the immunological specificity of the antigen-antibody reaction.
Discussion
In these experiments, size of the antibody-C'-induced membrane defects can be defined in terms of the size in solution of molecules which do or do not protect the cells against colloid osmotic lysis. A variety of methods have been used to assess the size and dimensions of macromolecules, and results have varied widely depending on techniques employed and the physical state of the molecules under the conditions of the test, as has been discussed by Edsall (32) . Based on X-ray studies of human albumin, Low (33) has suggested that the molecule has an elongated shape. (39) .
To describe the diffusion behavior of large molecules in solution through porous membranes, the effective diffusion radius, calculated from the Stokes-Einstein equation (Table III) , has been demonstrated by Pappenheimer (40) , Pappenheimer, Renkin, and Borrero (41) , and Ren-kin (42) to provide a useful and valid estimate of molecular size. The effective diffusion radius, simply stated, is the radius of a sphere with equivalent diffusion coefficient. Values of effective diffusion radii for the substances used in these experiments were taken from the literature and are listed in Table III .
By relating these estimates of molecular size to the present experimental results, the size of the antibody-C' induced membrane defects can be defined more specifically. The holes created by the rabbit antihuman red cell serum and human C' are approximately equal to the median molecular size of Dextran 20, molecular weight 20,000, or 32 A in effective radius. On the other hand, the holes produced by antihuman A of either human or rabbit origin and human C' must be greater than 32.5 A in effective radius. These estimates depend, of course, on the validity of the estimates of molecular size employed and the assumption that there are no significant interactions between the test molecules and the membrane "holes." They do, however, provide estimates of the relative size, in a functional sense, of the membrane lesions induced by these different antibodies and human C'.
In his original description of colloid-osmotic hemolysis, Wilbrandt considered lysis of sensitized sheep cells by C' to be nonosmotic on the basis of the shape of osmotic fragility curves (9) . However, as Ponder (45) 49) , which is far too slow to produce potassium losses of the magnitude observed after 2-hour incubations in the present studies.
The structural counterpart of the cell membrane of these physiologically demonstrated defects induced by antibody and C' is not known. They are much larger than the normal pores of the human red cell membrane, estimated by Solomon (50) to have a radius of about 3.5 A. The defects in the membrane, at least in the case of the more precisely defined lesion induced by the rabbit antihuman red cell serum, is of the same general order of size as the molecular cross sectional area calculated for rabbit antibodies against sheep cells by Heidelberger, Weil, and Treffers (51) . Latta (52) , studying antibody-lysed sheep erythrocytes with the electron microscope, described surface "cracks" in the affected cells. Goldberg and Green (11) have observed focal pouching and folding of the cell membrane with the electron microscope in ascites tumor cells treated with antibody and C'.
Complement alone does not appear to determine the size of the induced red cell membrane defects. Human C' was utilized in all of our experiments, and yet the size of the membrane defects varied with different antisera. The hypothesis may be proposed that the antigenic sites may have been critical in determining the size of the defect created by antibody and C'. All of the specific antigen(s) recognized by the antibody in the rabbit antihuman red cell serum used in these experiments is not known. Clearly, however, the antibodies were not directly primarily against antigens of the human ABO system. The rabbits were immunized with human group 0 red cells, and the antiserum, when tested against 983 the erythrocytes of all the human ABO groups, produced similar membrane defects that were smaller than those induced by anti-A sera.
Little is known of the distribution of antigen sites or functionally active sites on the surface of the red cell membrane. The technique employed in these experiments may provide an approach by which to evaluate whether the size of the erythrocyte membrane defect has a relationship to any structural characteristic of the involved antigens. Summary 1. Rabbit antihuman red cell serum and human complement (C') produce functional holes in human erythrocyte membranes that are 32 A in effective radius. Destruction of these injured cells in vitro ensues by colloid-osmotic lysis.
2. In contrast, antihuman A of rabbit and human origin with human complement produces holes greater than 32.5 A in radius, permitting direct escape of hemoglobin.
3. The size of the membrane defect is not related either to molecular size of the antibody molecules or to the species of animal producing the antibody. 4 . We suggest that specificity of the antigenic sites involved determines the size of the membrane defect produced. In turn, the mechanism of the complement-dependent hemolysis is determined by the size of the induced membrane defects.
